BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 179696)

  • 1. Herpes simplex virus-specific antigens in exfoliated cervical cells from women with and without cervical anaplasia.
    Pacsa AS; Kummerländer L; Pejtsik B; Krommer K; Pali K
    Cancer Res; 1976 Jul; 36(7 PT 1):2130-2. PubMed ID: 179696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herpes type-2 virus antigens in human cervical carcinoma.
    Adelusi B; Osunkoya BO; Fabiyi A
    Obstet Gynecol; 1976 May; 47(5):545-8. PubMed ID: 772507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of herpes simplex virus type-2 antigen(s) in biopsies from carcinoma of the uterine cervix.
    Thankamani V; Kumari TV; Vasudevan DM
    J Exp Pathol; 1985; 2(2):123-33. PubMed ID: 2431113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific non-immunoglobulin G antibodies and cell-mediated response to herpes simplex virus antigens in women with cervical carcinoma.
    Thiry L; Sprecher-Goldberger S; Hannecart-Pokorni E; Gould I; Bossens M
    Cancer Res; 1977 May; 37(5):1301-6. PubMed ID: 192446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reaction of antigens isolated from herpes simplex virus-transformed cells with sera of squamous cell carcinoma patients.
    Notter MF; Docherty JJ
    Cancer Res; 1976 Dec; 36(12):4394-401. PubMed ID: 187320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Papilloma virus in cervical carcinoma: detection of viral antigen in cancer cells.
    Thankamani V; Kumari TV; Vasudevan DM
    J Exp Pathol; 1992; 6(1-2):41-53. PubMed ID: 1320667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection of herpes simplex virus antigen in human cervical carcinoma tissue].
    Xu ZH
    Zhonghua Fu Chan Ke Za Zhi; 1986 Jul; 21(4):238-41, 254. PubMed ID: 3021401
    [No Abstract]   [Full Text] [Related]  

  • 8. An evaluation of herpes simplex virus antigenic markers in the study of established and developing cervical neoplasia.
    Smith CC; Aurelian L; Gupta PK; Frost JK; Rosenshein NB; Klacsmann K; Geddes S
    Anal Quant Cytol; 1980 Jun; 2(2):131-43. PubMed ID: 6255843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunofluorescence study of the presence of herpes type 1 and type 2 antigens in patients with cancer of the uterine cervix.
    Athanasiu P; Nastac E; Stoian M; Predescu E; Hozoc M
    Virologie; 1978; 29(4):251-3. PubMed ID: 219590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herpes simplex virus II antigen in adenocarcinoma of the uterine cervix.
    Bhatia A; Ashokraj G
    Indian J Pathol Microbiol; 1988 Apr; 31(2):40-4. PubMed ID: 2844663
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antibodies in patients with cervicouterine carcinoma].
    Gomez-Estrada H; Huerta-Sanchez R; Hernandez-Sanchez R; Garza-Eufrasio O; Venustiano-Carranza J; Miranda-Acevedo C; Terrazas-Flores JA; Fernandez-Quintero P
    Arch Invest Med (Mex); 1975; 6(1):13-22. PubMed ID: 169759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infection with herpes-simplex viruses 1 and 2. II.
    Nahmias AJ; Roizman B
    N Engl J Med; 1973 Oct; 289(14):719-25. PubMed ID: 4353782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic and biochemical characterization of individual polypeptides induced by herpes simplex virus types 1 and 2.
    Courtney RJ
    Adv Pathobiol; 1976; (5):87-103. PubMed ID: 220860
    [No Abstract]   [Full Text] [Related]  

  • 14. Natural history of precancerous and early cancerous lesions of the uterine cervix.
    Luthra UK; Prabhakar AK; Seth P; Agarwal SS; Murthy NS; Bhatnagar P; Das DK; Sharma BK
    Acta Cytol; 1987; 31(3):226-34. PubMed ID: 3035845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of herpes simplex virus type 2 (HSV-2) antibodies and antigens in patients with cervical carcinoma in Thailand.
    Puthavathana P; Srivatanakul P; Thanapatra S; Kosiyatrakul T; Phitakpraiwan P
    J Med Assoc Thai; 1980 Oct; 63(10):560-7. PubMed ID: 6255050
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibodies to herpes simplex virus types 1 and 2: a comparative study using indirect haemagglutination in carcinoma of the cervix and in other malignant conditions.
    Freymuth F; Morel C; Longson A; Tanguy M
    Biomedicine; 1975 Sep; 23(7):271-5. PubMed ID: 182291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibody to HSV2 protein as an immunodiagnostic marker in cervical cancer.
    Costa S; D'Errico A; Grigioni WF; Orlandi C; Smith CC; Mancini AM; Aurelian L
    Cancer Detect Prev Suppl; 1987; 1():189-205. PubMed ID: 2826000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral etiology of cervical carcinoma. Human papilloma virus and herpes simplex virus type 2.
    Meng XJ; Sun Y; Chen MH; Liu ZH; Zhang YX; Li XZ; Li K; Han RC; Si JY; Hu LY
    Chin Med J (Engl); 1989 Feb; 102(2):94-9. PubMed ID: 2550184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence and expression of the herpes simplex virus type 2 genome in cervical tumor cells.
    Aurelian L
    Cancer Res; 1974 May; 34(5):1126-35. PubMed ID: 4367156
    [No Abstract]   [Full Text] [Related]  

  • 20. Persistence and expression of the herpes simplex virus type 2 genome in cervical tumor cells.
    Aurelian L
    Clin Orthop Relat Res; 1974; (99):78-85. PubMed ID: 4363067
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.